Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Pain treatment start-up Solace takes in $15mm via Series A

Executive Summary

Pain medicines developer Solace Pharmaceuticals has raised $15mm in its Series A financing, which was co-led by new investors Polaris Venture Partners and InterWest Partners and included seed financier PureTech Ventures. Members of Polaris and InterWest joined the company's board.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies